Protecting human research participants is essential to the clinical research enterprise. When researchers engage in serious and continuing noncompliance with human subjects research regulations, their institutions must develop and implement action plans to address their noncompliance. However, developing appropriate and effective action plans is challenging, and ineffective action plans that do not change researchers' behavior put the researcher and institution at risk that noncompliance will reoccur. We propose an 8-month bioethics supplement that will be relevant to institutional officials charged with addressing human subjects compliance violations and developing action plans in response to these violations. The research team has expertise in researcher professional development, identifying root causes of noncompliance, and responsible behavior in research settings. The research team also has experience developing and conducting a national program intended for researchers referred to the program for noncompliance and research integrity violations. We propose the following aims:
Aim 1. Determine the procedures institutions utilize to develop action plans for serious and continuing noncompliance and identify a comprehensive set of root causes and associated actions and activities. 1A. Conduct in-depth interviews about action plan procedures, content, and perceived effectiveness with 36 institutional officials (IOs) who are experienced with handling cases of human subjects noncompliance to identify root cause-remedial activity linkages and inform the development of the Aim 1B survey. 1B. Administer a survey to institutional officials at all U.S. health science research institutions (n ? 170) to characterize broad action plan development practices, action plan content, and perceived effectiveness.
Aim 2. Convene 6 experts in responsible research to review Aim 1 results, P.I. Program root cause and development activities, and relevant professional development literature to create an action plan tool.

Public Health Relevance

When researchers engage in serious and continuing noncompliance with human subjects research regulations, institutions must develop and implement action plans to address this noncompliance. Complete and accurate identification of the root causes of noncompliance and linking these causes to appropriate actions is central to the effectiveness of these plans. Through interviews and surveys with institutional officials at biomedical research institutions and a review of findings conducted by six experts in research professional development and responsible behavior, we will describe approaches to action plan development and create a resource guide to inform the development of effective action plans.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR002345-04S2
Application #
10131496
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Gannot, Gallya
Project Start
2017-06-19
Project End
2022-02-28
Budget Start
2020-08-10
Budget End
2021-02-28
Support Year
4
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Bernard, Caitlin; Wan, Leping; Peipert, Jeffrey F et al. (2018) Comparison of an additional early visit to routine postpartum care on initiation of long-acting reversible contraception: A randomized trial. Contraception 98:223-227
McGill, Bryan E; Barve, Ruteja A; Maloney, Susan E et al. (2018) Abnormal Microglia and Enhanced Inflammation-Related Gene Transcription in Mice with Conditional Deletion of Ctcf in Camk2a-Cre-Expressing Neurons. J Neurosci 38:200-219
Casey, B J; Cannonier, Tariq; Conley, May I et al. (2018) The Adolescent Brain Cognitive Development (ABCD) study: Imaging acquisition across 21 sites. Dev Cogn Neurosci 32:43-54
Sato, Chihiro; Barthélemy, Nicolas R; Mawuenyega, Kwasi G et al. (2018) Tau Kinetics in Neurons and the Human Central Nervous System. Neuron 97:1284-1298.e7
Cherian, Mathew A; Olson, Sydney; Sundaramoorthi, Hemalatha et al. (2018) An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia. J Biol Chem 293:6844-6858
Altman, Matthew C; Whalen, Elizabeth; Togias, Alkis et al. (2018) Allergen-induced activation of natural killer cells represents an early-life immune response in the development of allergic asthma. J Allergy Clin Immunol 142:1856-1866
Cruchaga, Carlos; Del-Aguila, Jorge L; Saef, Benjamin et al. (2018) Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms. Alzheimers Dement 14:205-214
Lutkewitte, Andrew J; Schweitzer, George G; Kennon-McGill, Stefanie et al. (2018) Lipin deactivation after acetaminophen overdose causes phosphatidic acid accumulation in liver and plasma in mice and humans and enhances liver regeneration. Food Chem Toxicol 115:273-283
Van Buren, Dorothy J; Wilfley, Denise E; Marcus, Marsha D et al. (2018) Depressive symptoms and glycemic control in youth with type 2 diabetes participating in the TODAY clinical trial. Diabetes Res Clin Pract 135:85-87
Chen, Delphine L; Huang, Howard J; Byers, Derek E et al. (2018) The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study. PLoS One 13:e0191783

Showing the most recent 10 out of 416 publications